Download PDF
TumorDiagnostik & Therapie 2021; 42(07): 511-517
DOI: 10.1055/a-1506-7784
Thieme Onkologie aktuell

3 ungewöhnliche Verläufe von gastrointestinalen MALT-Lymphomen

3 unusual courses of gastrointestinal MALT lymphoma
Wolfgang Fischbach
1   Medizinische Klinik II, Klinikum Aschaffenburg-Alzenau
,
Matthias Eck
2   Pathologisches Institut, Klinikum Aschaffenburg-Alzenau
,
Christian Dorlöchter
1   Medizinische Klinik II, Klinikum Aschaffenburg-Alzenau
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Zusammenfassung

Wir berichten über den ungewöhnlichen Krankheitsverlauf von drei Patienten mit gastro-intestinalen MALT-Lymphomen. Besonderheiten sind die primäre Manifestation der Lymphome, die hochmaligne Transformation im weiteren Verlauf, der lange Zeitraum zwischen initial erfolgreicher kurativ intendierter Therapie und dem Rezidiv und das Auftreten einer weiteren Neoplasie in einem Fall. Dies zeigt, dass trotz der allgemein guten Prognose von gastrointestinalen MALT-Lymphomen Nachsorgeuntersuchungen sinnvoll sind.

Abstract

We report on the unusual course of disease in three patients with gastrointestinal MALT lymphoma. Special features are the primary lymphoma manifestation, the high-grade transformation during the follow up, the long-time interval between initially curative intended therapy and relapse and the occurrence of another neoplasia in one case. This demonstrates that despite their good prognosis in general, follow-up investigations of gastrointestinal MALT lymphoma are reasonable.

Schlüsselwörter

MALT-Lymphom - gastrointestinal - Lokalisation - Krankheitsverlauf - hochmaligne Transformation

Key words

MALT lymphoma - gastrointestinal - localization - course of disease - high-grade transformation


Publication History

Article published online:
30 August 2021

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Wündisch T, Dieckhoff P, Greene B. et al. Second cancers and Residual Disease in Patients Treated for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma by Helicobacter pylori Eradication and Followed for 10 Years. Gastroenterology 2012; 143: 936-942
    CrossrefPubMedGoogle Scholar
  • 2 Fischbach W, Dragosics B, Koelve-Goebeler ME. et al. Primary gastric B-cell Lymphoma: Results of a Prospective Multicenter Study. Gastroenterology 2000; 119: 1191-1202
    CrossrefPubMedGoogle Scholar
  • 3 Ruskoné-Fourmestraux A, Fischbach W, Aleman BMP. et al. EGILS consensus report.Gastric extranodal marginal zone B cell lymphoma of MALT. Gut 2011; 60: 747-758
    CrossrefPubMedGoogle Scholar
  • 4 Fischbach W, Malfertheiner P, Lynen Jansen P. et al. S2k Leitlinie H. pylori und gastroduo-denale Ulkuskrankheit. Z Gastroenterol 2016; 54: 327-363
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Fischbach W, Goebeler-Kolve ME, Dragosics B. et al. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication: experience from a large prospective series. GUT 2004; 53: 34-37
    CrossrefPubMedGoogle Scholar
  • 6 Zullo A, Hassan C, Cristofari F. et al. Effects of Helicobacter pylori Eradication on Early Stage Gastric Mucosa-Associated Lymphoid Tissue Lymphoma. Clin Gastroenterol Hepatol 2010; 8: 105-110
    CrossrefPubMedGoogle Scholar
  • 7 Fischbach W, Goebeler ME, Ruskone-Fourmestraux A. et al. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be safely managed by a watch-and-wait strategy. Experience from a large international series. Gut 2007; 56: 1685-1687
    CrossrefPubMedGoogle Scholar
  • 8 Fischbach W, Dorlöchter C. Patients with gastric MALT lymphoma revealing persisting endoscopic abnormalities after successful eradication of Helicobacter pylori can be safely managed by a watch-and-wait strategy. Z Gastroenterol 2019; 57: 593-599
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Eck M, Schmaußer W, Haas R. et al. MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the CagA protein. Gastroenterology 1997; 112: 1482-1486
    CrossrefPubMedGoogle Scholar
  • 10 Al-Taie O, Al-Taie E, Fischbach W. Patienten mit Helicobacter-pylori negativen gastralen Marginalzonen-B-Zell-Lymphomen (MZBZL) des MALT haben eine gute Prognose. Z Gastroenterol 2014; 52: 1389-1393
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Fischbach W. Colorectal MALT lymphoma: a rare clinical entity. Z Gastroenterol 2018; 56: 905-911
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Capelle LG, de Vries AC, Looman CWN. et al. Gastric MALT lymphoma: Epidemiology and high adenocarcinoma risk in a nation-wide study. Eur J Cancer 2008; 44: 2470-2476
    CrossrefPubMedGoogle Scholar
  • 13 Schechter NR, Portlock CS, Yahalom J. Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. J Clin Oncol 1998; 16: 916-1921
    CrossrefPubMedGoogle Scholar
  • 14 Tsang RW, Gospodarowicz MK, Pintilie M. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol 2003; 21: 4157-4164
    CrossrefPubMedGoogle Scholar
  • 15 Koch P, Probst A, Berdel WE. et al. Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96). J Clin Oncol 2005; 23: 7050-7059
    CrossrefPubMedGoogle Scholar
  • 16 Fischbach W, Schramm S, Goebeler E. Outcome and quality of life favour a conservative treatment of patients with primary gastric lymphoma. Z Gastroenterol 2011; 49: 430-435
    PubMedGoogle Scholar